Stenosis

·MeSH: Constriction, Pathologic

5 drugs in development·4 companies·1 clinical trial

Drug Pipeline by Phase

Approved(2)

Drug	Company
cofix	Xtant Medical Holdings, Inc. (XTNT)
coflex	Xtant Medical Holdings, Inc. (XTNT)

Phase 3(2)

Drug	Company
pelacarsen	Novartis AG (NVS)
virtue sab	Orchestra BioMed Holdings Inc. (OBIO)

Phase 1(1)

Drug	Company
pirfenidone 267 mg [esbriet]	GH Research PLC (GHRS)

BioSniper tracks 5 drugs in development for Stenosis across 4 companies.

There are 1 clinical trial targeting Stenosis tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.